Psychoactive drugs : (Record no. 2091)

MARC details
000 -LEADER
fixed length control field 02140nam a22002897a 4500
001 - CONTROL NUMBER
control field D0001B000108
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20201216144818.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201216b ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9241561122
040 ## - CATALOGING SOURCE
Description conventions rda
245 00 - TITLE STATEMENT
Title Psychoactive drugs :
Remainder of title improving prescribing practices /
Statement of responsibility, etc. edited by Hamid Ghodse and Inayat Khan
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Geneva :
Name of publisher, distributor, etc. WHO,
Date of publication, distribution, etc. 1988.
300 ## - PHYSICAL DESCRIPTION
Extent 99 pages.
336 ## - CONTENT TYPE
Source rdacontent
Content type text
337 ## - MEDIA TYPE
Source rdamedia
Media type unmediated
338 ## - CARRIER TYPE
Source rdacarier
Carrier type term volume
520 3# - SUMMARY, ETC.
Summary, etc. A wide-ranging analysis of what can be done to reduce the misuse of psychoactive drugs without compromising appreciation for their therapeutic value. The book opens with an overview of changing trends in the use and misuse of psychoactive drugs, including neuroleptics, antidepressants, hypnotic sedatives, and anxiolytics. Common patterns of inappropriate use, in developing as well as developed countries, are identified and different methods for assessing levels of use are critically compared. For each class of drug, readers are given brief information on dependence liability, therapeutic value, and social benefits. A timely reminder of good clinical practice is provided in a chapter outlining the principles of rational prescribing as these pertain to patients complaining of life stress, to patients whose complaints are related to disease states, and to doctor shoppers . Readers will also find a discussion of non-physical approaches that can be used to alleviate symptoms usually treated with psychoactive substances. The remaining chapters concentrate on the importance of physician education as a strategy for reducing the misuse of psychoactive drugs on the largest possible scale.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psychotropic Drugs
General subdivision administration and dosage therapeutic use
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mental Disorders
General subdivision drug therapy
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prescription Drugs
General subdivision standards
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ghodse, Hamid
Relator term editor
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Khan, Inayat
Relator term editor
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element World Health Organization
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://apps.who.int/iris/bitstream/handle/10665/37296/9241561122.pdf?sequence=1&isAllowed=y">https://apps.who.int/iris/bitstream/handle/10665/37296/9241561122.pdf?sequence=1&isAllowed=y</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme National Library of Medicine
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     DOH Central Library DOH Central Library WHO Publication Section 12/16/2020   QV 77.88 PSY 1988 D0001B000108 12/16/2020 12/16/2020 Book